Lauromacrogol foam injection under ultrasonic guidance for pediatric lip venous malformations
link.springer.com shows its articles on its own site.
Read the article on link.springer.com ↗Article · Jan 2023 · 1 min read
In brief
In brief
This retrospective study of 52 pediatric patients demonstrates that ultrasound-guided lauromacrogol foam sclerotherapy is an effective and safe treatment for lip venous malformations, achieving a 90.38% success rate with minimal complications. Patients required an average of 4 treatment sessions over 14 months of follow-up.
Written by the GCMD Library team from the article.
Abstract
Objective
To evaluate the efficacy and safety of lauromacrogol foam sclerotherapy in the treatment of children with lip venous malformation.
Methods
Fifty-two children (27 males and 25 females) aged from 6 months to 17 years with lip VM who underwent lauromacrogol foam injection with ultrasonic guidance from July 2018 to December 2020 in our hospital were retrospectively recruited for this study. All the children were examined by MRI, ultrasound, blood routine and coagulation before operation. We were guided by ultrasound to locate the blood flow area (nests), injecting lauromacrogol foam to fill the venous malformation. The follow-up time was 14.31 ± 5.96 (6–24) months. Follow-up items include clinical manifestations, imaging data, efficacy and complications.
Results
This group of children was treated 3–5 times, an average of 4 times/case. The total effective rate was 90.38%. Pain in 4 cases, fever in 4 cases, infection in 2 cases, ulcer in 1 case. There were no serious complications such as cardiopulmonary accident.
Conclusion
Ultrasound guiding foam sclerotherapy with lauromacrogol is effective and safe for children with lip venous malformation.